Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 12, 2025 · 10-Q · 42 days after period end · 0001641172-25-009746
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$1.02M | -$865.97K | -$3.71M | -$689.50K |
| EPS Diluted | -$1.92 | -$1.31 | -$55.20 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end
